Stuttgart
11.08.26 | 13:31
26,400 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 27,500 | 28,340 | 07:39 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| XVIVO PERFUSION Aktie jetzt für 0€ handeln | |||||
| Di | Xvivo Perfusion AB: XVIVO receives CE certificates for its groundbreaking heart preservation technology, transforming access to life-saving transplants across Europe | 102 | GlobeNewswire (Europe) | CAUTION-Investigational device in the US. Limited by Federal (United States) law to investigational use. The safety and effectiveness of this device have not been established. The XVIVO heart technology... ► Artikel lesen | |
| 03.08. | XVIVO Perfusion AB: XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport | 277 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / August 3, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the US Food and Drug Administration (FDA) has granted the company approval... ► Artikel lesen | |
| 14.07. | Xvivo Perfusion AB (publ) reports Q2 results | 2 | Seeking Alpha | ||
| 14.07. | Xvivo Perfusion AB Q2 Profit Rises | 3 | RTTNews | ||
| 14.07. | XVIVO übertrifft im Q2 die Umsatzerwartungen dank starkem Thorax-Geschäft | 1 | Investing.com Deutsch | ||
| 14.07. | XVIVO Perfusion AB: Interim Report January - June 2026 | 396 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 14, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Second quarter 2026 (Apr-Jun)Net sales amounted to SEK 239.0 million (178.3), corresponding to a growth... ► Artikel lesen | |
| 09.07. | OneLegacy Partners with XVIVO and Perfusion Solution to Launch the First Ex Vivo Lung Perfusion (EVLP) Center in the Western U.S. | 346 | Business Wire | OneLegacy, the nonprofit organ procurement organization serving Southern California, announced the launch of the first in-house Ex Vivo Lung Perfusion (EVLP) program at an organ procurement organization... ► Artikel lesen | |
| 26.06. | XVIVO Perfusion AB: Conference call on Interim Report April-June 2026 | 423 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / June 26, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report April-June 2026. The... ► Artikel lesen | |
| 18.05. | XVIVO Perfusion AB: Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology | 390 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / May 18, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Hôpital La Pitié-Salpêtrière (Sorbonne University) in Paris, France, has, since the approval of... ► Artikel lesen | |
| 27.04. | Bulletin from Annual General Meeting in XVIVO Perfusion AB | 318 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 27, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV):The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO Perfusion... ► Artikel lesen | |
| 24.04. | Xvivo Perfusion AB (publ) GAAP EPS of SEK1.15, revenue of SEK241M | 1 | Seeking Alpha | ||
| 24.04. | XVIVO Perfusion AB: Interim Report January - March 2026 | 210 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 24, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2026 (Jan-Mar)Net sales amounted to SEK 241.0 million (218.6), corresponding to growth... ► Artikel lesen | |
| 24.04. | Xvivo Perfusion AB: Interim Report January - March 2026 | 219 | GlobeNewswire (Europe) | First quarter 2026 (Jan-Mar)• Net sales amounted to SEK 241.0 million (218.6), corresponding to growth of 10 percent in SEK.• Organic growth was 23 percent in local currencies. Excluding revenue from... ► Artikel lesen | |
| 22.04. | XVIVO Perfusion AB: XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion In Direct Procurement DCD Heart Transplantation | 498 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, the results from the HOPE-at-Heart clinical trial (NCT06485596) were presented at the ISHLT... ► Artikel lesen | |
| 22.04. | XVIVO Perfusion AB: Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO's Heart Technology Presented at ISHLT in Toronto | 442 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, preliminary one-year follow-up data from the US PRESERVE trial of XVIVO's investigational... ► Artikel lesen | |
| 22.04. | Late-Breaking Data from PRESERVE Trial Evaluates XVIVO's HOPE Preservation Approach in Heart Transplantation | 459 | Business Wire | Preliminary results suggest potential to support extended preservation time and donor heart utilization XVIVO, a global medtech company in the organ transplant industry, today announced late-breaking... ► Artikel lesen | |
| 17.04. | XVIVO Perfusion AB: Conference Call on Interim Report January-March 2026 | 345 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 17, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report January-March 2026.... ► Artikel lesen | |
| 16.04. | XVIVO Perfusion AB: The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal | 348 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 16, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - At last year's ISHLT congress, in April 2025, the one-year results from the European multicenter... ► Artikel lesen | |
| 02.04. | Xvivo Perfusion AB (publ) GAAP EPS of SEK 0.80, revenue of SEK 812.2M | 4 | Seeking Alpha | ||
| 01.04. | XVIVO Perfusion AB: Annual Report 2025 | 426 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 1, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today XVIVO Perfusion AB (publ) publish the Annual Report for 2025. The Annual Report is attached... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 31,080 | +3,60 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Rheinmetall, Deutsche Telekom, Siemens, Airbnb & Lyft | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,940 | +0,29 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| INTUITIVE SURGICAL | 347,95 | +0,10 % | Intuitive Surgical: Ist der Abverkauf die große Chance? | ||
| RHOEN-KLINIKUM | 14,800 | +4,23 % | EQS-News: RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG mit weiterhin stabiler Entwicklung im Halbjahr 2026 | EQS-News: RHÖN-KLINIKUM Aktiengesellschaft
/ Schlagwort(e): Halbjahresergebnis/Sonstiges
RHÖN-KLINIKUM AG mit weiterhin stabiler Entwicklung im Halbjahr 2026
06.08.2026... ► Artikel lesen | |
| BICO GROUP | 1,562 | -0,13 % | BICO Preis heute: Rückgang auf unter 0,043 Dollar in 60 Minuten | ||
| M1 KLINIKEN | 19,000 | +1,06 % | Dividendenbekanntmachungen (09.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCENTURE PLC IE00B4BNMY34 1,63 USD 1,4275 EUR ALIMENTATION COUCHE-TARD INC CA01626P1484 0,215 CAD 0,1328 EUR ANPARIO PLC GB00B3NWT178 0... ► Artikel lesen | |
| BAXTER | 23,990 | +0,25 % | Baxter International: Interims-Finanzchefin Anita Zielinski tritt im September zurück | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| JD HEALTH INTERNATIONAL | 4,253 | -0,67 % | JD HEALTH (06618): DATE OF BOARD MEETING | ||
| COOPER COMPANIES | 65,53 | -1,56 % | Cooper Companies Posts Q2 Loss Hurt By One-Time Litigation Charge, Revenue Rises 8% | WASHINGTON (dpa-AFX) - Cooper Companies, Inc. (COO) on Thursday posted a net loss due to a substantial litigation-related charge tied to a 2023 product recall. However, the company reported... ► Artikel lesen | |
| LIFEWARD | 7,680 | +0,66 % | Lifeward Out With Q2 Numbers | ||
| BONESUPPORT | 20,500 | +0,10 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen | |
| ONWARD MEDICAL | 2,415 | +0,42 % | ONWARD Medical NV: ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones | EINDHOVEN, the Netherlands, May 26, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| COMMUNITY HEALTH SYSTEMS | 2,460 | -1,60 % | Community Health Systems forecasts 2026 adjusted EBITDA of $1.3B-$1.375B amid softer elective surgeries and higher uninsured volumes | ||
| RAMSAY HEALTH CARE | 27,400 | +0,74 % | Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares |
XVIVO PERFUSION AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 26,400 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu XVIVO PERFUSION AB finden Sie auf Wallstreet Online.